Analysis of Intestinal Defensin Expression in Patients With Acute Graft-versus-Host Disease (GVHD)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- Defensin Expression (peptide)
研究概览
简要总结
This study has the aim to analyze intestinal expression of endogenous antimicrobial peptides in patients with acute GVHD. The expression will be compared to intestinal expression of defensins in patients with colitis and patients without intestinal inflammation.
详细描述
Acute graft-versus-host disease (GVHD) is a major cause of morbidity and mortality in patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT). Acute GVHD is characterized by complex deficiencies of the mucosal antimicrobial barrier and intestinal dysbiosis, which contribute to disease pathogenesis. Defensins are endogenous epithelial cell-derived antimicrobial peptides, which can protect epithelial barrier integrity, shape the intestinal microbiota composition and contribute to host immunoregulation. Deregulated expression of defensins has been reported in patients with colitis, including Chron's Disease and ulcerative colitis.
In this study, the investigators aim to analyze the expression of defensins in the intestine of patients with acute GVHD to study whether it is deregulated. The results will be valuable to study the role of defensins during acute GVHD pathogenesis or as potential biomarkers for disease activity.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 99 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •age ≥ 18 years
- •diagnostic endoscopy was performed
- •diagnosis results available
- •written informed consent
- •ability to understand the nature of the study and the study related procedures and to comply with them
排除标准
- •age < 18 years
- •gastrointestinal cancer
- •lack of informed consent
结局指标
主要结局
Defensin Expression (peptide)
时间窗: 3 years
Analysis of alpha-defensin and beta-defensin levels by immunohistochemistry
Defensin Expression (mRNA)
时间窗: 3 years
Analysis of alpha-defensin and beta-defensin mRNA expression by realtime PCR (qRT-PCR)
次要结局
未报告次要终点
研究者
Robert Zeiser
Director of the Division of Tumor Immunology
University of Freiburg
